Autophagy as a therapeutic target in cancer

par Chen, Ning, Karantza, Vassiliki
Publié 2011

The interplay between autophagy and ROS in tumorigenesis

par Kongara, Sameera, Karantza, Vassiliki
Publié 2012

Autophagy and cancer cell metabolism

par Lozy, Fred, Karantza, Vassiliki
Publié 2012

Molecular Pathways: Autophagy in Cancer—A Matter of Timing and Context

par Cicchini, Michelle, Karantza, Vassiliki, Xia, Bing
Publié dans Clin Cancer Res (2014)

p62: a hub of multiple signaling pathways in HER2-induced mammary tumorigenesis

par Cai-McRae, Xiaofeng, Karantza, Vassiliki
Publié dans Mol Cell Oncol (2015)

Current treatment landscape for patients with locally recurrent inoperable or metastatic triple-negative breast cancer: a systematic literature review

par Li, Claire H., Karantza, Vassiliki, Aktan, Gursel, Lala, Mallika
Publié dans Breast Cancer Res (2019)

Time-restricted feeding and the realignment of biological rhythms: translational opportunities and challenges

par Sunderram, Jag, Sofou, Stavroula, Kamisoglu, Kubra, Karantza, Vassiliki, Androulakis, Ioannis P
Publié 2014

The protein kinase Pak4 disrupts mammary acinar architecture and promotes mammary tumorigenesis

par Liu, Yingying, Chen, Ning, Cui, Xiaoxing, Zheng, Xi, Deng, Li, Price, Sandy, Karantza, Vassiliki, Minden, Audrey
Publié 2010

Autophagy inhibition by chloroquine sensitizes HT-29 colorectal cancer cells to concurrent chemoradiation

par Schonewolf, Caitlin A, Mehta, Monal, Schiff, Devora, Wu, Hao, Haffty, Bruce G, Karantza, Vassiliki, Jabbour, Salma K
Publié 2014

ATG proteins mediate efferocytosis and suppress inflammation in mammary involution

par Teplova, Irina, Lozy, Fred, Price, Sandy, Singh, Sukhwinder, Barnard, Nicola, Cardiff, Robert D., Birge, Raymond B., Karantza, Vassiliki
Publié 2013

ERBB2 overexpression suppresses stress-induced autophagy and renders ERBB2-induced mammary tumorigenesis independent of monoallelic Becn1 loss

par Lozy, Fred, Cai-McRae, Xiaofeng, Teplova, Irina, Price, Sandy, Reddy, Anupama, Bhanot, Gyan, Ganesan, Shridar, Vazquez, Alexei, Karantza, Vassiliki
Publié 2014

Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity

par Cicchini, Michelle, Chakrabarti, Rumela, Kongara, Sameera, Price, Sandy, Nahar, Ritu, Lozy, Fred, Zhong, Hua, Vazquez, Alexei, Kang, Yibin, Karantza, Vassiliki
Publié dans Autophagy (2014)

Autophagy regulates keratin 8 homeostasis in mammary epithelial cells and in breast tumors

par Kongara, Sameera, Kravchuk, Olga, Teplova, Irina, Lozy, Fred, Schulte, Jennifer, Moore, Dirk, Barnard, Nicola, Neumann, Carola A., White, Eileen, Karantza, Vassiliki
Publié 2010

Autophagy opposes p53-mediated tumor barrier to facilitate tumorigenesis in a model of PALB2-associated hereditary breast cancer

par Huo, Yanying, Cai, Hong, Teplova, Irina, Bowman-Colin, Christian, Chen, Guanghua, Price, Sandy, Barnard, Nicola, Ganesan, Shridar, Karantza, Vassiliki, White, Eileen, Xia, Bing
Publié 2013

Phase I study of gemcitabine, docetaxel and imatinib in refractory and relapsed solid tumors

par Saraiya, Biren, Chugh, Rashmi, Karantza, Vassiliki, Mehnert, Janice, Moss, Rebecca A., Savkina, Nelli, Stein, Mark N., Baker, Laurence H., Chenevert, Thomas, Poplin, Elizabeth A.
Publié dans Invest New Drugs (2010)

Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study

par Nanda, Rita, Chow, Laura Q.M., Dees, E. Claire, Berger, Raanan, Gupta, Shilpa, Geva, Ravit, Pusztai, Lajos, Pathiraja, Kumudu, Aktan, Gursel, Cheng, Jonathan D., Karantza, Vassiliki, Buisseret, Laurence
Publié dans J Clin Oncol (2016)

Metabotropic glutamate receptor 1 disrupts mammary acinar architecture and initiates malignant transformation of mammary epithelial cells

par Teh, Jessica L. F., Shah, Raj, La Cava, Stephanie, Dolfi, Sonia C., Mehta, Madhura S., Kongara, Sameera, Price, Sandy, Ganesan, Shridar, Reuhl, Kenneth R., Hirshfield, Kim M., Karantza, Vassiliki, Chen, Suzie
Publié dans Breast Cancer Res Treat (2015)

Rationally designed treatment for solid tumors with MAPK pathway activation: a Phase I study of paclitaxel and bortezomib using an adaptive dose-finding approach

par Mehnert, Janice M., Tan, Antoinette R., Moss, Rebecca, Poplin, Elizabeth, Stein, Mark N., Sovak, Mika, Levinson, Kelly, Lin, Hongxia, Kane, Michael, Gounder, Murugesan, Lin, Yong, Shih, Weichung Joe, White, Eileen, Rubin, Eric H., Karantza, Vassiliki
Publié 2011

Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis

par Guo, Jessie Yanxiang, Chen, Hsin-Yi, Mathew, Robin, Fan, Jing, Strohecker, Anne M., Karsli-Uzunbas, Gizem, Kamphorst, Jurre J., Chen, Guanghua, Lemons, Johanna M.S., Karantza, Vassiliki, Coller, Hilary A., DiPaola, Robert S., Gelinas, Celine, Rabinowitz, Joshua D., White, Eileen
Publié 2011

Autophagy in malignant transformation and cancer progression

par Galluzzi, Lorenzo, Pietrocola, Federico, Bravo-San Pedro, José Manuel, Amaravadi, Ravi K, Baehrecke, Eric H, Cecconi, Francesco, Codogno, Patrice, Debnath, Jayanta, Gewirtz, David A, Karantza, Vassiliki, Kimmelman, Alec, Kumar, Sharad, Levine, Beth, Maiuri, Maria Chiara, Martin, Seamus J, Penninger, Josef, Piacentini, Mauro, Rubinsztein, David C, Simon, Hans-Uwe, Simonsen, Anne, Thorburn, Andrew M, Velasco, Guillermo, Ryan, Kevin M, Kroemer, Guido
Publié dans EMBO J (2015)